The market clearly doesn't care for anymore assays, and neither do I. I bought into RVR over 2 years ago as the company was presenting to investors they could quickly get Hillgrove back online at low cost to add another source of revenue. IMO management dragged their heels on prioritizing that at as stated. Did they not want to spend the money at the time whilst the royalty debacle dragged on? So here we are with investors including myself fed up, but selling whilst our MC is this low is absurd. RVR need to lift their marketing game and let investors know WTH is going on, as we shouldn't be relying on anecdotal reports from persons on the ground who are not company employees.
RVR Price at posting:
14.8¢ Sentiment: Hold Disclosure: Held
